ING Operating Expenses

ING Group, N.V. Common Stock · Operating Expenses

ING logo

ING Operating Expenses

Latest reported€29.40B EUR
ING TTM Operating Expenses · EUR (€24.08B → €29.40B)
High-resolution chart · PNG

ING operating expenses history

Trailing twelve months (TTM) · EUR. Each value covers four complete reported quarters.

ING Group, N.V. Common Stock Operating Expenses — Trailing twelve months (TTM) (EUR)
Period endingOperating Expenses (EUR)
29,395,000,000
31,115,000,000
31,094,000,000
31,093,000,000
31,031,000,000
34,440,000,000
30,448,000,000
30,187,000,000
30,074,000,000
24,985,000,000
28,849,000,000
28,661,000,000
28,497,000,000
16,384,000,000
16,257,000,000
16,316,000,000
16,372,000,000
14,968,000,000
15,040,000,000
15,008,000,000
14,936,000,000
16,432,000,000
16,248,000,000
30,140,000,000
29,966,000,000
31,817,000,000
31,772,000,000
31,365,000,000
32,008,000,000
30,819,000,000
30,718,000,000
16,935,000,000
16,021,000,000
7,471,000,000
7,428,000,000
4,811,000,000
4,852,000,000
7,010,000,000
7,094,000,000
9,615,000,000
9,629,000,000
9,367,000,000
8,877,000,000
9,012,000,000
9,011,000,000
9,330,000,000
9,984,000,000
9,724,000,000
9,650,000,000
8,547,000,000
11,058,000,000
17,787,000,000
23,516,000,000
30,365,000,000
34,966,000,000
44,539,000,000
46,714,000,000
47,181,000,000
48,570,000,000
96,355,000,000
97,040,000,000
102,520,000,000
103,120,000,000
46,729,000,000
46,168,000,000
42,674,000,000
42,753,000,000
50,941,873,000
56,493,873,000
60,788,873,000
66,570,873,000
65,226,456,000
65,312,733,000
65,951,733,000
63,952,485,000
62,438,714,000
61,633,499,000
62,328,799,000
62,834,995,000
62,913,600,000
63,321,538,000
62,543,076,000
61,073,270,000
60,539,787,000
59,956,787,000
58,848,946,000
59,060,550,000
59,703,564,000
59,146,761,550
58,687,807,550
60,675,609,550
61,909,253,240
63,366,766,770
67,567,078,770
68,665,677,770
80,596,371,090
72,434,692,310
73,112,498,310
64,330,723,310
55,153,557,300
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.